Sigma Healthcare Ltd Share Price Australian S.E.
Equities
AU000000SIP6
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- AUD | - |
05-10 | Sigma Healthcare Limited(ASX:SIG) added to S&P/ASX 200 Index | CI |
05-02 | Boral to Exit S&P/ASX 200 Index Following Takeover Bid | MT |
Sales 2025 * | 6.39B 4.28B 337B | Sales 2026 * | 6.83B 4.57B 361B | Capitalization | 1.96B 1.31B 104B |
---|---|---|---|---|---|
Net income 2025 * | 485M 324M 25.59B | Net income 2026 * | 573M 383M 30.23B | EV / Sales 2025 * | 0.39 x |
Net Debt 2025 * | 522M 349M 27.54B | Net Debt 2026 * | 544M 364M 28.69B | EV / Sales 2026 * | 0.37 x |
P/E ratio 2025 * |
29.8
x | P/E ratio 2026 * |
25
x | Employees | - |
Yield 2025 * |
2.72% | Yield 2026 * |
3.2% | Free-Float | 92.29% |
Latest transcript on Sigma Healthcare Ltd
Managers | Title | Age | Since |
---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 53 | 31/01/22 |
Mark Conway
DFI | Director of Finance/CFO | - | 10-31 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | 05/10/23 |
Kathryn Spargo
BRD | Director/Board Member | 72 | 08/12/15 |
Michael Sammells
CHM | Chairman | - | 31/01/20 |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 71.7B | |
-3.41% | 23.73B | |
+10.27% | 9.01B | |
+11.24% | 8.72B | |
-18.91% | 8.29B | |
+16.00% | 5B | |
+17.83% | 4.48B | |
-2.11% | 4.08B | |
-1.72% | 3.92B |